Polycystic ovary syndrome influences the level of serum amyloid A and activity of phospholipid transfer protein in HDL2 and HDL3
Author(s) -
Sonia Gidwani,
Niall Phelan,
Janet B. McGill,
Anne McGowan,
Andrew O’Connor,
Ian Young,
James Gibney,
Jane McEneny
Publication year - 2014
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/deu115
Subject(s) - medicine , phospholipid transfer protein , endocrinology , serum amyloid a , polycystic ovary , serum amyloid a protein , insulin resistance , blood lipids , cholesterol , diabetes mellitus , phospholipid , inflammation , chemistry , biochemistry , membrane
Is polycystic ovary syndrome (PCOS) associated with altered levels of pro-inflammatory high-density lipoproteins (HDL) and activity of HDL-associated enzymes?
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom